Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?

CONCLUSIONS: Most of our type 2 diabetes patients, treated with low-premixed insulin, did not meet the recommended TBR target for older/high-risk patients while meeting the TIR and TAR targets. Nevertheless, the time spent in (total and nocturnal) hypoglycemia was short. The study indicates that the general type 2 diabetes population targets would mostly be met for TBR and %CV in our patients but not the TIR and TAR targets. CGM appears to be a useful clinical tool in these patients.PMID:36882852 | DOI:10.1186/s40001-023-01081-y

Source: Molecular Medicine - March 7, 2023 Category: Molecular Biology Authors: Mitja Krajnc Nika Aleksandra Kravos Tram šek Source Type: research